Page 74 - Read Online

Zhang et al. Cancer Drug Resist 2024;7:30 https://dx.doi.org/10.20517/cdr.2024.62 Page 11 of 13

progranulin (PGRN) in the pathogenesis and prognosis of breast cancer. Cytokine 2022;151:155803. DOI PubMed
5. He B, Zhao Z, Cai Q, et al. miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci 2020;16:2628-47. DOI
PubMed PMC
6. Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol 2016;231:25-30. DOI PubMed PMC
7. Syed R, Davey MG, Richard V, Miller N, Kerin MJ. Biological implications of MicroRNAs as regulators and biomarkers of
therapeutic toxicities in breast cancer. Int J Mol Sci 2023;24:12694. DOI PubMed PMC
8. Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech 2021;14:dmm047662. DOI PubMed PMC
9. Vishnoi A, Rani S. miRNA biogenesis and regulation of diseases: an updated overview. Methods Mol Biol 2023;2595:1-12. DOI
PubMed
10. Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics,
and analysis methods. J Cell Physiol 2019;234:5451-65. DOI PubMed
11. Ho PTB, Clark IM, Le LTT. MicroRNA-based diagnosis and therapy. Int J Mol Sci 2022;23:7167. DOI PubMed PMC
12. Zeng Y, Du W, Huang Z, et al. Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging
miR-1205. Cell Death Discov 2023;9:153. DOI PubMed PMC
13. Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature
2013;495:333-8. DOI PubMed
14. Ashwal-Fluss R, Meyer M, Pamudurti NR, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell 2014;56:55-66.
DOI PubMed
15. Yarmishyn AA, Ishola AA, Chen CY, et al. Circular RNAs modulate cancer hallmark and molecular pathways to support cancer
progression and metastasis. Cancers 2022;14:862. DOI PubMed PMC
16. Li Y, Wang Z, Yang J, et al. CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing
CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation. Mol Cancer 2024;23:102. DOI PubMed PMC
17. Song X, Wang X, Chen X, Yu Z, Zhou Y. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast
cancer cells through the circSEPT9/GCH1 axis. J Proteomics 2024;292:105055. DOI PubMed
18. Wang H, Wang X, Shen W, et al. CircRNA (circ)_0007823 contributes to triple-negative breast cancer progression and cisplatin
resistance via the miR-182-5p/FOXO1 pathway. Biochem Genet 2024:1-13. DOI
19. Michlewski G, Cáceres JF. Post-transcriptional control of miRNA biogenesis. RNA 2019;25:1-16. DOI PubMed PMC
20. Matsuyama H, Suzuki HI. Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis. Int J Mol Sci
2019;21:132. DOI PubMed PMC
21. Pietrykowska H, Sierocka I, Zielezinski A, et al. Biogenesis, conservation, and function of miRNA in liverworts. J Exp Bot
2022;73:4528-45. DOI PubMed PMC
22. Tafrihi M, Hasheminasab E. MiRNAs: Biology, biogenesis, their web-based tools, and databases. Microrna 2019;8:4-27. DOI
PubMed
23. Do DN, Dudemaine PL, Mathur M, Suravajhala P, Zhao X, Ibeagha-Awemu EM. miRNA regulatory functions in farm animal
diseases, and biomarker potentials for effective therapies. Int J Mol Sci 2021;22:3080. DOI PubMed PMC
24. Kilikevicius A, Meister G, Corey DR. Reexamining assumptions about miRNA-guided gene silencing. Nucleic Acids Res
2022;50:617-34. DOI PubMed PMC
25. Pu M, Chen J, Tao Z, et al. Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional
regulation of gene expression. Cell Mol Life Sci 2019;76:441-51. DOI PubMed PMC
26. Yang L, Wilusz JE, Chen LL. Biogenesis and regulatory roles of circular RNAs. Annu Rev Cell Dev Biol 2022;38:263-89. DOI
PubMed PMC
27. Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol 2020;21:475-90. DOI
PubMed
28. Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol 2016;17:205-11. DOI PubMed
29. Huang X, Song C, Zhang J, Zhu L, Tang H. Circular RNAs in breast cancer diagnosis, treatment and prognosis. Oncol Res
2023;32:241-9. DOI PubMed PMC
30. Zhu Y, Huang G, Li S, et al. CircSMARCA5: a key circular RNA in various human diseases. Front Genet 2022;13:921306. DOI
PubMed PMC
31. Wang Z, Yang L, Wu P, et al. The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting
the selective autophagy of afadin. Mol Cancer 2022;21:29. DOI PubMed PMC
32. Li Z, Ruan Y, Zhang H, Shen Y, Li T, Xiao B. Tumor-suppressive circular RNAs: mechanisms underlying their suppression of tumor
occurrence and use as therapeutic targets. Cancer Sci 2019;110:3630-8. DOI PubMed PMC
33. Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell 2018;71:428-42. DOI PubMed
34. Wu S, Lu J, Zhu H, et al. A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer.
Cancer Lett 2024;581:216508. DOI PubMed
35. Zhang M, Bai X, Zeng X, Liu J, Liu F, Zhang Z. circRNA-miRNA-mRNA in breast cancer. Clin Chim Acta 2021;523:120-30. DOI
PubMed
36. Huang A, Zheng H, Wu Z, Chen M, Huang Y. Circular RNA-protein interactions: functions, mechanisms, and identification.
Theranostics 2020;10:3503-17. DOI PubMed PMC